Boc-D-aspartic acid β-benzyl ester
Need Assistance?
  • US & Canada:
    +
  • UK: +

Boc-D-aspartic acid β-benzyl ester

* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.

Category
BOC-Amino Acids
Catalog number
BAT-002709
CAS number
51186-58-4
Molecular Formula
C16H21NO6
Molecular Weight
323.30
Boc-D-aspartic acid β-benzyl ester
IUPAC Name
(2S)-2-[(2-methylpropan-2-yl)oxycarbonylamino]-4-oxo-4-phenylmethoxybutanoic acid
Synonyms
Boc-D-Asp(OBzl)-OH; (R)-4-(Benzyloxy)-2-((tert-butoxycarbonyl)amino)-4-oxobutanoic acid
Appearance
White to off-white powder
Purity
≥ 99% (HPLC)
Density
1.175±0.06 g/cm3(Predicted)
Melting Point
101-103 °C
Boiling Point
437.6±45.0 °C(Predicted)
Storage
Store at 2-8°C
InChI
InChI=1S/C16H21NO6/c1-16(2,3)23-15(21)17-12(14(19)20)9-13(18)22-10-11-7-5-4-6-8-11/h4-8,12H,9-10H2,1-3H3,(H,17,21)(H,19,20)/t12-/m1/s1
InChI Key
SOHLZANWVLCPHK-GFCCVEGCSA-N
Canonical SMILES
CC(C)(C)OC(=O)NC(CC(=O)OCC1=CC=CC=C1)C(=O)O

Boc-D-aspartic acid β-benzyl ester, a pivotal intermediate in peptide synthesis and pharmaceutical research, plays a crucial role in multiple applications. Here are four key applications described with a high level of perplexity and burstiness:

Peptide Synthesis: At the core of peptide synthesis, Boc-D-aspartic acid β-benzyl ester emerges as a prominent figure. Widely embraced for its utility in crafting peptides, this compound acts as a shielded amino acid derivative. Its Boc group, the stalwart protector of the amino group during peptide assembly, harmonizes with the β-benzyl ester, guardian of the carboxyl group. Together, they streamline the synthesis and purification journey, ushering in a realm of high-purity peptide creations.

Drug Development: In the realm of pharmaceutical exploration, Boc-D-aspartic acid β-benzyl ester takes center stage in generating peptide-based therapeutic contenders. This compound orchestrates the precise integration of D-aspartic acid into peptide sequences, elevating the stability, bioavailability, and efficacy of potential medicines. Researchers harness the power of this ester to architect and fabricate innovative peptides aimed at combatting diverse ailments, forging a path towards revolutionary treatments.

Chemical Biology: Delving into the intricate world of chemical biology, scholars wield Boc-D-aspartic acid β-benzyl ester as a catalyst for unraveling protein-protein and protein-ligand interactions. By infusing this ester into peptides and biomolecules, scientists birth analogs and probes that unveil the mysteries of biological mechanisms.

Proteomics: Embarking on a journey within the realm of proteomics, Boc-D-aspartic acid β-benzyl ester emerges as a beacon for probing and characterizing proteins and peptides. This compound spearheads the preparation of labeled peptides, paving the way for meticulous mass spectrometry exploration. Through this avenue, proteins within intricate biological samples are identified and quantified, propelling the fields of diagnostics, biomarker exploration, and personalized medicine into a realm of boundless possibilities and transformative discoveries.

1.Synthesis and fast-atom-bombardment-mass spectrometry of N-acetylmuramoyl-L-alanyl-D-isoglutamine (MDP).
Phillips LR, Nishimura O, Fraser BA. Carbohydr Res. 1984 Sep 15;132(2):275-86.
N-Acetylmuramoyl-L-alanyl-D-isoglutamine (MDP) was synthesized by a series of condensations of appropriate reagents, followed by hydrogenolysis. Each intermediate step resulted in a stable, crystalline product. D-Isoglutamine 4-benzyl ester was condensed with N-(tert-butoxycarbonyl)-L-alanine N-hydroxysuccinimide ester, to give N-(tert-butoxycarbonyl)-L-alanyl-D-isoglutamine benzyl ester. Condensation of L-alanyl-D-isoglutamine benzyl ester with N-acetyl-1-O-benzyl-4,6-O-benzylidenemuramic acid, followed by hydrogenolysis, gave MDP. The synthetic scheme was shown to be capable of producing gram quantities of highly pure MDP, as well as a few of its analogs. The synthetic MDP was characterized by analytical and biological methods, and it was found that the use of fast-atom-bombardment-mass spectrometry may greatly simplify the characterization process.
2.Design, synthesis and binding properties of novel and selective 5-HT(3) and 5-HT(4) receptor ligands.
Modica M1, Santagati M, Guccione S, Russo F, Cagnotto A, Goegan M, Mennini T. Eur J Med Chem. 2000 Dec;35(12):1065-79.
This work reports the synthesis and the binding tests on the 5-HT(3) and 5-HT(4) receptors of new thienopyrimidopiperazine and piperazinylacylaminodimethylthiophene derivatives, in order to identify potent and selective ligands for each receptor. The compound with higher affinity and selectivity for the 5-HT(3) over the 5-HT(4) receptor was the 3-amino-2-(4-benzyl-1-piperazinyl)-5,6-dimethyl-thieno[2,3-d]pyrimidin-4(3H)-one 28 (5-HT(3) K(i)=3.92 nM, 5-HT(4) not active), the compound with higher affinity and selectivity for the 5-HT(4) over the 5-HT(3) receptor was the 2-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butanoylamino]-4,5-dimethyl-3-thiophenecarboxylic acid ethyl ester 41 (5-HT(4) K(i)=81.3 nM, 5-HT(3) not active). Conformational analyses were carried out on the compounds of the piperazinylacylaminodimethylthiophene series (39-42) taking compound 41 as the template.
3.Stereoselective synthesis of dipeptide beta-turn mimetics: 7-benzyl and 8-phenyl substituted azabicyclo[4.3.0]nonane amino acid esters.
Wang W1, Yang J, Ying J, Xiong C, Zhang J, Cai C, Hruby VJ. J Org Chem. 2002 Sep 6;67(18):6353-60.
A stereoselective method has been developed for the synthesis of 7- and 8-substituted dipeptide beta-turn mimetic azabicyclo[4.3.0]nonane amino acid esters. The allyl groups were introduced in high diastereoselectivity, controlled by 3-phenyl or 4-benzyl groups in pyroglutamic acid derivatives 3 or 9, respectively. The precursors, dehydroamino acids 7 and 13 derived from 5 or 11, underwent asymmetric hydrogenations with Burk's DuPHOS Rh(I)-based catalysts to furnish alpha-amino acid derivatives in high stereoselectivity. The resulting amino acids 8 and 14 were converted to the beta-turn mimetics 6,5-bicyclic lactams 1a-d in high yields.
4.Synthesis of the two monomethyl esters of the disaccharide 4-O-alpha-D-galacturonosyl-D-galacturonic acid and of precursors for the preparati
Magaud D1, Grandjean C, Doutheau A, Anker D, Shevchik V, Cotte-Pattat N, Robert-Baudouy J. Carbohydr Res. 1998 Dec 31;314(3-4):189-99.
Methyl (alpha-D-galactopyranosyluronic acid)-(1-->4)-D-galactopyranuronate and methyl alpha-D-galactopyranosyl-uronate-(1-->4)-D-galactopyranuronic acid have been synthesized by coupling methyl (benzyl 2,3-di-O-benzyl-beta-D-galactopyranosid)uronate (3) or benzyl (benzyl 2,3-di-O-benzyl-beta-D-galactopyranosid)uronate (4) with benzyl (phenyl 2,3,4-tri-O-benzyl-1-thio-beta-D-galactopyranosid)uronate and methyl (phenyl 2,3,4-tri-O-benzyl-1-thio-beta-D-galactopyranosid)uronate, respectively, using N-iodosuccinimide and trifluoromethanesulphonic acid as promoters, followed by removal of the benzyl groups. The 4'-OH unprotected dimers benzyl (methyl 2,3-di-O-benzyl-alpha-D-galactopyranosyluronate)-(1-->4)-(benzyl 2,3-di-O-benzyl-beta-D-galactopyranosid)uronate and methyl (benzyl 2,3-di-O-benzyl-alpha-D-galactopyranosyluronate)-(1-->4)-(benzyl 2,3-di-O-benzyl-beta-D-galactopyranosid)uronate were prepared from methyl (phenyl 2,3-di-O-benzyl-1-thio-4-O-trimethylsilyl-beta-D-galactopyranosid) uronate and benzyl (phenyl 2,3-di-O-benzyl-1-thio-4-O-trimethylsilyl-beta-D-galactopyranosid) uronate and acceptors 4 or 3, respectively.
Online Inquiry
Verification code
Inquiry Basket